Publicacións (145) Publicacións de Eduardo Barge Caballero

2024

  1. Destination Therapy Strategies of Advanced Heart Failure in Elderly Non-Heart Transplant Candidates: A Propensity Matching Analysis from the LEVO-D and REGALAD Registries

    Life, Vol. 14, Núm. 12

  2. Different impact of chronic kidney disease in older patients with heart failure according to frailty

    European Journal of Internal Medicine

  3. Incidence and causes of hospitalization in patients with transthyretin (ATTR-CA) and light chain (AL-CA) cardiac amyloidosis

    Medicina Clinica, Vol. 162, Núm. 7, pp. e1-e7

  4. Predicting the development of heart failure in patients with atrial fibrillation

    Revista Espanola de Cardiologia, Vol. 77, Núm. 9, pp. 720-722

  5. Prognostic impact of chronic obstructive pulmonary disease and bronchial asthma in patients with heart failure

    Revista Clinica Espanola, Vol. 224, Núm. 3, pp. 123-132

  6. Prognostic value of the tricuspid annular plane systolic excursion/systolic pulmonary artery pressure ratio in cardiac amyloidosis

    Revista Espanola de Cardiologia, Vol. 77, Núm. 8, pp. 634-644

  7. Reduced mitochondrial pyruvate carrier expression in hearts with heart failure and reduced ejection fraction patients: ischemic vs. non-ischemic origin

    Frontiers in Cardiovascular Medicine, Vol. 11

  8. Review of the allocation criteria for heart transplant in Spain in 2023. SEC-Heart Failure Association/ONT/SECCE consensus document

    Revista Espanola de Cardiologia, Vol. 77, Núm. 1, pp. 69-78

  9. Use of SGLT2i in patients with transthyretin amyloid cardiomyopathy: prevalence and safety in a Spanish prospective cohort

    Revista Espanola de Cardiologia, Vol. 77, Núm. 4, pp. 349-352

  10. Use of a surgically implanted, nondischargeable, extracorporeal continuous flow circulatory support system as a bridge to heart transplant

    Revista espanola de cardiologia (English ed.), Vol. 77, Núm. 1, pp. 39-49

2023

  1. Clinical outcomes in heart transplant recipients with coronary abnormalities in the donor graft

    Revista Espanola de Cardiologia, Vol. 76, Núm. 6, pp. 473-474

  2. Current situation of the comprehensive approach of heart failure in Spain. The OPTIMISE-IC project

    REC: CardioClinics, Vol. 58, Núm. 4, pp. 289-302

  3. Durable ventricular assist device in Spain (2007-2020). First report of the REGALAD registry

    Revista Espanola de Cardiologia, Vol. 76, Núm. 4, pp. 227-237

  4. Evaluación de la intervención educativa enfermera y adherencia terapéutica a los inmunosupresores en pacientes trasplantados de corazón

    Enfermería en cardiología: revista científica e informativa de la Asociación Española de Enfermería en Cardiología, Núm. 88, pp. 34-43

  5. Fulminant myocarditis proven by early biopsy and outcomes

    European Heart Journal, Vol. 44, Núm. 48, pp. 5110-5124

  6. How does age affect outcomes after left ventricular assist device implantation: results from the PCHF-VAD registry

    ESC Heart Failure, Vol. 10, Núm. 2, pp. 884-894

  7. Mechanical circulatory support in severe primary graft dysfunction: Peripheral cannulation but not earlier implantation improves survival in heart transplantation

    Journal of Heart and Lung Transplantation, Vol. 42, Núm. 8, pp. 1101-1111

  8. Mortality After the First Hospital Admission for Acute Heart Failure, De Novo Versus Acutely Decompensated Heart Failure With Reduced Ejection Fraction

    American Journal of Cardiology, Vol. 196, pp. 59-66

  9. Prevalence, Characteristics, and Prognostic Relevance of Donor-Transmitted Coronary Artery Disease in Heart Transplant Recipients

    Journal of the American College of Cardiology, Vol. 82, Núm. 9, pp. 753-767